Mangement of Pulmonary Emboli

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-20

Study Completion Date

2027-12-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess to which extent we are adherent to ESC guidelines 2019 in management of patients presented with acute pulmonary embolism

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hydro-mechanical Defragmentation of Pulmonary Embolism

NCT04099186

Pulmonary Embolism

COMPLETED NA

Prognostic Tools in Patients With Acute Pulmonary Thromboembolism.

NCT04237974

Pulmonary Embolism

UNKNOWN

Role of MRI in Diagnosis of Pulmonary Embolism

NCT03754673

Pulmonary Embolism

COMPLETED

Surgery in Pulmonary Embolisms

NCT06070129

Pulmonary Embolism

NOT_YET_RECRUITING

Clinical Pulmonary Embolism

NCT05469724

Acute Pulmonary Embolism

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pulmonary embolism (PE) is the third most frequent cardiovascular disease and is associated with a high mortality burden PE is defined as the obstruction of a pulmonary artery, mostly resulting from the dislodgement of thrombotic material from the lower limbs. It has a wide variety of presentations, ranging from an asymptomatic incidental finding to circulatory collapse and sudden death Pulmonary embolism response teams (PERTs) have emerged as a multidisciplinary team for managing acute pulmonary embolism, with a rapid activation process for multimodality assessment, risk stratification and best management especially for complex challenge cases. PERTs help in improving time to PE diagnosis; shorter time to initiation of anticoagulation reducing hospital length of stay, increasing use of advanced therapies as catheter directed therapies without an increase in bleeding complications with decreasing mortality

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Embolism (Diagnosis)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

To assess to which extent we are adherent to ESC guidelines 2019 in management of patients presented

Comparing ESC 2019 criteria for risk stratification and mortality with new scores \[BOVA , modified FAST, PEITHO-3 models \& POPE\].

-Comparing management and outcomes of in hospital and 30 days follow up of pulmonary embolism before and after starting PERT in our center

No interventions assigned to this group